مقالههای دارای تعهدات انتشار عمومی - Yoseph Rozenmanبیشتر بدانید
جای دیگری دردسترس است: ۵
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
تعهدات: UK Medical Research Council
European Society of Cardiology: cardiovascular disease statistics 2019
A Timmis, N Townsend, CP Gale, A Torbica, M Lettino, SE Petersen, ...
European heart journal 41 (1), 12-85, 2020
تعهدات: British Heart Foundation, UK Medical Research Council, National Institute …
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The lancet Diabetes & endocrinology 7 (8), 618-628, 2019
تعهدات: US National Institutes of Health, National Institute for Health Research, UK
Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment
GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ...
Diabetes Care 44 (5), 1219-1227, 2021
تعهدات: US National Institutes of Health, National Institute for Health Research, UK …
Prediction of readmissions and mortality in patients with heart failure: lessons from the IMPEDANCE‐HF extended trial
M Kleiner Shochat, M Fudim, A Shotan, DS Blondheim, M Kazatsker, ...
ESC heart failure 5 (5), 788-799, 2018
تعهدات: US National Institutes of Health
اطلاعات انتشارات و تأمین بودجه بهطورخودکار توسط برنامه رایانهای تعیین میشود.